Sign in

CIK 0000899923

  • Accelerated filer

MYRIAD GENETICS INC

Sign in to watch
Ticker
MYGN
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870494517
Phone
+1 801-584-3600
Business address
322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
Former names
MYRIAD GENETICS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-09-25 Verratti Mark President Assurex Health Inc. Returned to the company −2,897 $12.44 $36K 116,429
2020-09-25 Verratti Mark President Assurex Health Inc. Returned to the company −2,897 $12.44 $36K 113,532
2020-09-25 LANCHBURY JERRY S Chief Scientific Officer Returned to the company −5,544 $12.44 $69K 220,764
2020-09-25 LANCHBURY JERRY S Chief Scientific Officer Returned to the company −4,214 $12.44 $52K 216,550
2020-09-24 Ford Alexander Chief Operating Officer Grant or award +41,000 192,159
2020-09-24 Riggsbee Richard Bryan Chief Financial Officer Grant or award +41,000 296,491
2020-09-24 Verratti Mark President Assurex Health Inc. Grant or award +32,800 119,326
2020-09-24 LANCHBURY JERRY S Chief Scientific Officer Grant or award +32,800 226,308
2020-09-17 Kumar Rashmi Director Grant or award +23,923 23,923
2020-09-15 Ford Alexander Chief Operating Officer Sale −2,804 $13.78 $39K 151,159
2020-08-12 Jackson Benjamin E.V.P., General Counsel Grant or award +6,541 62,537
2020-08-12 Lambert Nicole President, MGL Grant or award +7,646 66,796
2020-08-12 Ford Alexander President, MWH Grant or award +11,525 153,963
2020-08-12 Riggsbee Richard Bryan Chief Financial Officer Grant or award +13,787 255,491
2020-08-12 Verratti Mark President Assurex Health Inc. Grant or award +7,467 86,526
2020-08-12 LANCHBURY JERRY S Chief Scientific Officer Grant or award +10,068 193,508
2010-02-18 Capone Mark Christopher Chief Operating Officer, MGL Exercise or conversion +5,000 $7.27 $36K 40,454
2010-02-18 Capone Mark Christopher Chief Operating Officer, MGL Exercise or conversion +2,000 $8.63 $17K 42,454
2010-02-18 Capone Mark Christopher Chief Operating Officer, MGL Exercise or conversion · Incentive Stock Option (right to buy) −5,000 20,000
2010-02-18 Capone Mark Christopher Chief Operating Officer, MGL Exercise or conversion · Incentive Stock Option (right to buy) −2,000 10,000

Page 32 of 35 · 689 trades